# Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/combination-of-empagliflozin-and-linagliptin-as-second-line-therapy-in-subjects/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ralph A. DeFronzo,Andrew Lewin,Sanjay Patel,Dacheng Liu,Renee Kaste,Hans J. Woerle,Uli C. Broedl |
| Citations | 294 |
| DOI | 10.2337/dc14-2364 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2134652590 |
| PMID | 25583754 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Andrew Lewin](https://scholariq.org/researchers/andrew-lewin/)
- [Uli C. Broedl](https://scholariq.org/researchers/uli-c-broedl/)

## Paper journal

- [Diabetes Care](https://scholariq.org/journals/diabetes-care/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.